Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes

Bhatti, M., Michail, O., Ayton, S., Gollop, N. D., Ryding, A., Rushworth, S., Bowles, K. and Flather, M. (2018) Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes. European Heart Journal, 39 (Supplement 1). p. 747. ISSN 0195-668X

Full text not available from this repository. (Request a copy)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	LivePure Connector
Date Deposited:	06 May 2020 00:07
Last Modified:	06 Feb 2025 09:03
URI:	https://ueaeprints.uea.ac.uk/id/eprint/75039
DOI:	10.1093/eurheartj/ehy563.P3612

Actions (login required)

View Item